{"id":"NCT00471328","sponsor":"Novartis Pharmaceuticals","briefTitle":"Efficacy and Safety of Nilotinib (AMN107) Compared With Current Treatment Options in Patients With GIST Who Have Failed Both Imatinib and Sunitinib","officialTitle":"A Randomized, Open-label, Multi-center Study to Evaluate the Efficacy of Nilotinib Versus Best Supportive Care With or Without a Tyrosine Kinase Inhibitor (Investigator's Choice) in Adult Patients With Gastrointestinal Stromal Tumors Resistant to Both Imatinib and Sunitinib","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-03","primaryCompletion":"2008-08","completion":"2011-06","firstPosted":"2007-05-09","resultsPosted":"2011-05-17","lastUpdate":"2012-06-12"},"enrollment":248,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Gastrointestinal Stromal Tumors"],"interventions":[{"type":"DRUG","name":"Nilotinib","otherNames":["AMN107, TasignaÂ®"]},{"type":"OTHER","name":"Best Supportive Care (BSC) +/- imatinib or sunitinib","otherNames":[]}],"arms":[{"label":"Nilotinib","type":"EXPERIMENTAL"},{"label":"Control/cross-over to Nilotinib","type":"ACTIVE_COMPARATOR"}],"summary":"The study evaluated the safety and efficacy of nilotinib versus current treatment in adults with gastrointestinal stromal tumors (GIST) who have either progressed or who were intolerant to the first and second line treatments.","primaryOutcome":{"measure":"Progression-free Survival (PFS) From Central Radiology Review Based on Primary Analysis (Data Cut-off: June, 2008)","timeFrame":"Up to 16 months","effectByArm":[{"arm":"Nilotinib","deltaMin":109,"sd":null},{"arm":"Control/Cross Over to Nilotinib","deltaMin":111,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":5},"locations":{"siteCount":35,"countries":["United States","Australia","Austria","Canada","Czechia","France","Germany","Italy","Netherlands","Poland","South Korea","Spain","Switzerland"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":81,"n":165},"commonTop":["Nausea","Abdominal pain","Decreased appetite","Fatigue","Vomiting"]}}